Collegium Pharmaceutical, Inc.

Total Valuation

Collegium Pharmaceutical, Inc. carries a market capitalization of 763.17M, placing it among publicly traded companies globally. Its enterprise value stands at 2.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Collegium Pharmaceutical, Inc. currently has 32.50M shares outstanding.

Valuation Ratios

Collegium Pharmaceutical, Inc. trades at a trailing price-to-earnings ratio of 24.13. The price-to-sales ratio is 1.43, and the price-to-book ratio stands at 3.77.

Enterprise Valuation

On an enterprise value basis, Collegium Pharmaceutical, Inc. trades at an EV/EBITDA multiple of 5.48 and an EV/FCF ratio of 5.66. The EV/Sales ratio of 2.65 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.62 provides insight into valuation relative to core operating earnings.

Financial Position

Collegium Pharmaceutical, Inc. maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 351.55, indicating elevated leverage, while an interest coverage ratio of 5.12 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Collegium Pharmaceutical, Inc. posts a return on equity of 17.61 and a return on invested capital of 7.80.

Taxes

Over the trailing twelve months, Collegium Pharmaceutical, Inc. has paid 29.77M in income taxes, reflecting an effective tax rate of 38.32.

Stock Price Statistics

Collegium Pharmaceutical, Inc.'s stock has declined approximately -38.59603% over the past 52 weeks. The 50-day moving average sits at 31.85, while the 200-day moving average is 38.06.

Income Statement

Over the trailing twelve months, Collegium Pharmaceutical, Inc. generated 808.21M in revenue and converted that into 47.92M in net income, yielding earnings per share of 1.26. EBITDA reached 391.00M, while operating income came in at 157.40M.

Balance Sheet

Collegium Pharmaceutical, Inc. holds 129.47M in cash and equivalents against 1.10B in total debt, resulting in a net debt position of 962.09M. Total book value stands at 311.91M, with working capital of 18.15M providing operational flexibility.

Cash Flow

Collegium Pharmaceutical, Inc. produced 329.92M in operating cash flow over the past twelve months. After subtracting -1.64M in capital expenditures, free cash flow totaled 328.28M - equivalent to 10.28 per share.

Margins

Collegium Pharmaceutical, Inc. operates with a gross margin of 60.02, reflecting its pricing power and cost economics. The operating margin of 19.48 and net profit margin of 5.93 provide insight into operational efficiency.

Dividends & Yields

Scores

Collegium Pharmaceutical, Inc. posts an Altman Z-Score of 1.98, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.